GlassScriptPhysician profile
Derar Albashaireh
NPI 1083902431
$7,744.41
in general payments reported to CMS, 2019-2025
24 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,808 · 2020: $139 · 2021: $474 · 2022: $2,052 · 2023: $1,372 · 2024: $1,187 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839 · Travel and Lodging: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,839.11 |
| Travel and Lodging | $431.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,792.41 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $1,390.43 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| Abiomed | $957.44 | 2021-2025 | Impella |
| Boston Scientific Corporation | $785.02 | 2019-2025 | General - Therapies, Watchman Flx, Avvigo Guidance System |
| Abbott Laboratories | $674.59 | 2019-2025 | Mitraclip, Cardiomems, Navitor |
| Shockwave Medical, INC | $170.92 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $167.32 | 2019-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $149.87 | 2024 | Indigo System |
| Verge Medical, INC. | $143.92 | 2023 | |
| Medtronic Vascular, INC. | $113.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.30 | 2019-2022 | |
| Cardiva Medical, INC. | $50.67 | 2021 | |
| Pfizer INC. | $42.85 | 2019-2024 | |
| Teleflex LLC | $34.93 | 2023 | Manta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.38 | 2023 | Lifevest |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.66 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.26 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $21.13 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.96 | 2022 | |
| Chiesi USA, INC. | $19.08 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $17.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.15 | 2019 | |
| Kestra Medical Technology Services, INC. | $14.75 | 2023 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derar Albashaireh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.